Dura Pharmaceuticals Case Study Help

Dura Pharmaceuticals is currently among the biggest food chains worldwide. It was founded by Harvard in 1866, a German Pharmacist who initially released "FarineLactee"; a combination of flour and milk to feed infants and reduce mortality rate. At the very same time, the Page siblings from Switzerland also found The Anglo-Swiss Condensed Milk Business. The 2 became competitors in the beginning but later on merged in 1905, leading to the birth of Dura Pharmaceuticals.
Business is now a transnational company. Unlike other international business, it has senior executives from different countries and attempts to make decisions thinking about the entire world. Dura Pharmaceuticals presently has more than 500 factories worldwide and a network spread across 86 nations.

Purpose

The function of Business Corporation is to boost the quality of life of people by playing its part and providing healthy food. While making sure that the company is succeeding in the long run, that's how it plays its part for a much better and healthy future

Vision

Dura Pharmaceuticals's vision is to offer its consumers with food that is healthy, high in quality and safe to consume. Business imagines to develop a well-trained workforce which would help the company to grow
.

Mission

Dura Pharmaceuticals's mission is that as currently, it is the leading business in the food industry, it believes in 'Excellent Food, Excellent Life". Its objective is to offer its consumers with a variety of choices that are healthy and best in taste. It is focused on providing the very best food to its consumers throughout the day and night.

Products.

Dura Pharmaceuticals has a broad range of products that it uses to its consumers. In 2011, Business was noted as the most gainful company.

Goals and Objectives

• Remembering the vision and objective of the corporation, the company has actually laid down its objectives and goals. These objectives and goals are listed below.
• One objective of the company is to reach no garbage dump status. It is working toward no waste, where no waste of the factory is landfilled. It encourages its workers to take the most out of the spin-offs. (Business, aboutus, 2017).
• Another goal of Dura Pharmaceuticals is to waste minimum food throughout production. Most often, the food produced is lost even before it reaches the clients.
• Another thing that Business is working on is to improve its product packaging in such a method that it would help it to lower the above-mentioned issues and would also ensure the delivery of high quality of its products to its clients.
• Meet international standards of the environment.
• Develop a relationship based on trust with its consumers, service partners, workers, and government.

Critical Issues

Just Recently, Business Company is focusing more towards the technique of NHW and investing more of its earnings on the R&D technology. The nation is investing more on acquisitions and mergers to support its NHW method. The target of the company is not attained as the sales were anticipated to grow greater at the rate of 10% per year and the operating margins to increase by 20%, given in Display H.

Situational Analysis.

Analysis of Current Strategy, Vision and Goals

The existing Business strategy is based upon the concept of Nutritious, Health and Health (NHW). This technique handles the idea to bringing change in the consumer preferences about food and making the food stuff much healthier concerning about the health issues.
The vision of this method is based on the key technique i.e. 60/40+ which merely indicates that the products will have a score of 60% on the basis of taste and 40% is based upon its dietary worth. The products will be manufactured with extra nutritional value in contrast to all other items in market getting it a plus on its nutritional material.
This strategy was adopted to bring more delicious plus healthy foods and beverages in market than ever. In competition with other companies, with an intention of maintaining its trust over customers as Business Company has gained more relied on by customers.

Quantitative Analysis.

R&D Spending as a percentage of sales are declining with increasing actual amount of spending shows that the sales are increasing at a greater rate than its R&D spending, and enable the company to more spend on R&D.
Net Revenue Margin is increasing while R&D as a percentage of sales is declining. This indication also shows a thumbs-up to the R&D costs, mergers and acquisitions.
Financial obligation ratio of the company is increasing due to its costs on mergers, acquisitions and R&D advancement instead of payment of debts. This increasing financial obligation ratio posture a risk of default of Business to its investors and might lead a decreasing share costs. Therefore, in regards to increasing financial obligation ratio, the company must not invest much on R&D and must pay its existing financial obligations to reduce the threat for financiers.
The increasing risk of financiers with increasing financial obligation ratio and declining share rates can be observed by big decrease of EPS of Dura Pharmaceuticals stocks.
The sales development of company is also low as compare to its mergers and acquisitions due to slow perception building of customers. This slow growth also hinder business to additional spend on its mergers and acquisitions.( Business, Business Financial Reports, 2006-2010).
Note: All the above analysis is done on the basis of estimations and Graphs given up the Exhibits D and E.

TWOS Analysis

TWOS analysis can be used to derive various methods based on the SWOT Analysis offered above. A brief summary of TWOS Analysis is given in Display H.

Strategies to exploit Opportunities using Strengths

Business ought to introduce more ingenious items by large amount of R&D Spending and mergers and acquisitions. It might increase the marketplace share of Business and increase the earnings margins for the business. It might also offer Business a long term competitive benefit over its rivals.
The global growth of Business need to be concentrated on market capturing of developing nations by expansion, bring in more customers through consumer's commitment. As establishing countries are more populous than developed countries, it might increase the consumer circle of Business.

Strategies to Overcome Weaknesses to Exploit Opportunities

Dura Pharmaceuticals must do mindful acquisition and merger of companies, as it might affect the consumer's and society's understandings about Business. It should get and combine with those business which have a market track record of healthy and nutritious business. It would improve the understandings of customers about Business.
Business ought to not just invest its R&D on development, rather than it needs to also focus on the R&D costs over evaluation of cost of different healthy items. This would increase expense efficiency of its products, which will lead to increasing its sales, due to declining prices, and margins.

Strategies to use strengths to overcome threats

Business needs to transfer to not only establishing however likewise to developed nations. It needs to broadens its geographical expansion. This large geographical expansion towards establishing and established nations would minimize the danger of possible losses in times of instability in various countries. It ought to broaden its circle to numerous countries like Unilever which operates in about 170 plus nations.

Strategies to overcome weaknesses to avoid threats

Dura Pharmaceuticals should sensibly manage its acquisitions to avoid the risk of misconception from the customers about Business. It must obtain and combine with those countries having a goodwill of being a healthy company in the market. This would not only enhance the perception of customers about Business but would also increase the sales, profit margins and market share of Business. It would likewise enable the company to use its possible resources efficiently on its other operations instead of acquisitions of those companies slowing the NHW strategy development.

Segmentation Analysis

Demographic Segmentation

The demographic division of Business is based upon four elements; age, gender, earnings and profession. For example, Business produces numerous items associated with infants i.e. Cerelac, Nido, etc. and associated to grownups i.e. confectionary items. Dura Pharmaceuticals products are rather cost effective by practically all levels, but its major targeted customers, in terms of earnings level are middle and upper middle level customers.

Geographical Segmentation

Geographical segmentation of Business is made up of its existence in almost 86 countries. Its geographical segmentation is based upon 2 main elements i.e. average income level of the customer in addition to the environment of the region. For example, Singapore Business Business's division is done on the basis of the weather of the region i.e. hot, warm or cold.

Psychographic Segmentation

Psychographic segmentation of Business is based upon the personality and lifestyle of the client. For instance, Business 3 in 1 Coffee target those customers whose life style is quite busy and do not have much time.

Behavioral Segmentation

Dura Pharmaceuticals behavioral division is based upon the attitude understanding and awareness of the client. For example its highly nutritious products target those customers who have a health mindful attitude towards their consumptions.

Dura Pharmaceuticals Alternatives

In order to sustain the brand in the market and keep the consumer intact with the brand, there are 2 options:
Alternative: 1
The Business ought to spend more on acquisitions than on the R&D.
Pros:
1. Acquisitions would increase overall possessions of the business, increasing the wealth of the company. Nevertheless, spending on R&D would be sunk expense.
2. The company can resell the obtained units in the market, if it stops working to execute its strategy. Nevertheless, amount invest in the R&D might not be restored, and it will be considered entirely sunk cost, if it do not provide potential outcomes.
3. Investing in R&D offer sluggish development in sales, as it takes very long time to present a product. Acquisitions supply quick outcomes, as it provide the company currently developed item, which can be marketed quickly after the acquisition.
Cons:
1. Acquisition of business's which do not fit with the company's worths like Kraftz foods can lead the company to deal with misconception of customers about Business core values of healthy and healthy items.
2 Large spending on acquisitions than R&D would send out a signal of business's ineffectiveness of establishing ingenious products, and would lead to customer's dissatisfaction as well.
3. Big acquisitions than R&D would extend the line of product of the company by the products which are already present in the market, making company not able to present new ingenious products.
Option: 2.
The Company needs to invest more on its R&D instead of acquisitions.
Pros:
1. It would enable the company to produce more innovative items.
2. It would supply the company a strong competitive position in the market.
3. It would make it possible for the company to increase its targeted clients by introducing those products which can be provided to an entirely new market sector.
4. Ingenious products will provide long term benefits and high market share in long term.
Cons:
1. It would decrease the profit margins of the company.
2. In case of failure, the whole costs on R&D would be considered as sunk cost, and would affect the company at large. The threat is not in the case of acquisitions.
3. It would not increase the wealth of company, which might supply a negative signal to the financiers, and might result I declining stock rates.
Alternative 3:
Continue its acquisitions and mergers with significant costs on in R&D Program.
Pros:
1. It would permit the company to introduce brand-new innovative products with less risk of converting the spending on R&D into sunk expense.
2. It would offer a favorable signal to the financiers, as the general properties of the company would increase with its significant R&D spending.
3. It would not affect the profit margins of the business at a large rate as compare to alternative 2.
4. It would provide the company a strong long term market position in regards to the company's overall wealth along with in regards to ingenious items.
Cons:
1. Threat of conversion of R&D costs into sunk cost, greater than alternative 1 lesser than alternative 2.
2. Threat of misconception about the acquisitions, greater than alternative 2 and lower than option 1.
3. Introduction of less number of innovative products than alternative 2 and high variety of innovative items than alternative 1.

Dura Pharmaceuticals Conclusion

Business has actually stayed the leading market gamer for more than a years. It has actually institutionalised its methods and culture to align itself with the marketplace modifications and client behavior, which has actually eventually enabled it to sustain its market share. Though, Business has actually developed considerable market share and brand identity in the metropolitan markets, it is advised that the business needs to focus on the rural areas in terms of establishing brand name loyalty, awareness, and equity, such can be done by creating a particular brand allowance technique through trade marketing tactics, that draw clear difference between Dura Pharmaceuticals items and other rival items. Moreover, Business needs to take advantage of its brand picture of safe and healthy food in catering the rural markets and also to upscale the offerings in other classifications such as nutrition. This will allow the company to establish brand name equity for recently presented and already produced products on a greater platform, making the reliable use of resources and brand name image in the market.

Dura Pharmaceuticals Exhibits